Item 7.01. Regulation FD Disclosure

On April 18, 2022, Innovation1 Biotech Inc. (the "Company") posted a presentation (the "Presentation") to its website and it is available in the Presentations section of the Company's website at https://www.innovation1bio.com/company-information/presentations. A copy of the Presentation is included as Exhibit 99.1 to this Current Report.

The Company intends to use the Presentation in presentations to investors and analysts from time to time in the future. The furnishing of the information in this Current Report is not intended to, and does not, constitute a determination by the Company that the information in this Current Report is material or complete, or that investors should consider this information before making an investment decision with respect to any security of the Company. The information in the materials is presented as of April 14, 2022, and the Company does not assume any obligation to update such information in the future.

The information in Item 7.01 of this Current Report shall not be deemed to be "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.





(d)     Exhibits



  99.1       Innovation1 Biotech Inc. Presentation.
104        Cover Page Interactive Data File (embedded within the Inline XBRL
           Document).





2

© Edgar Online, source Glimpses